Global Microbiome Therapeutics Market Report By Type (FMT, Microbiome Drugs), Application (C. Difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2017-2024
ID:VMR11210021
April 2018
Report Formats:

Microbiomes refers to the microorganisms residing in a particular environment, community or ecosystem. Basically, these microorganisms flourish in the areas like saliva, gastrointestinal tract (GT), etc. These microorganisms include bacteria, archaebacterial and fungi among many more. Microbiome Therapeutics refers to the development and advancement of therapies which interact with the gut microbiomes to improve the status of human health. The increasing number of population affected by inflammatory bowel diseases is the prime factor driving the microbiome therapeutics market.

As per Value Market Research, the Global Microbiome Therapeutics Market is expected to be worth USD 327.9 Million by 2024 with a CAGR of 45.7%.
 
FMT EMERGE AS THE LEADING TYPE SEGMENT
Fecal Microbiota Transplant (FMT) is widely used in microbiome therapeutics. FMT market is rapidly growing owing to its properties such as cost-effective, having low risk and highly effective treatment. The market for FMT has estimated to touch USD XX.X Million revenue by the end of 2024.
 
C. DIFFICILE EMERGES AS THE LARGEST APPLICATION OF MICROBIOME THERAPEUTICS
As per the study of Centers for Disease Control and Prevention (CDC), half of a million people are affected by C. difficile infection in the United States is majorly driving the segment growth. Further, the increasing number of death (approximately 29000 in the 30 days of initial diagnosis) caused life-threatening infection is again fueling the growth. It is estimated to reach USD XX.X Million revenue by the end of 2024.
 
NORTH AMERICA MARKET IS GAINING THE MOMENTUM
North America is accounted for the remarkable growth in the microbiome therapeutics market owing to the growing number of aging population. Additionally, the well-established research facilities along with the availability of advanced novel therapeutics are again fueling the regional growth. Further, the presence of key players helps North America to dominate the market. As a result, North America is expected to reach USD XX.X Million by the end of 2024.
 
PROMINENT PLAYERS IN THE GLOBAL MARKET
Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. are the major players driving in the global microbiome therapeutics market.

As per this study, the Global Microbiome Therapeutics Market was valued at USD 24.4 Million (by revenue) in 2017 and is anticipated to reach USD 327.9 Million by 2024 with a CAGR of 45.7%.
 
Microbiomes refers to the microorganisms residing in a particular environment, community or ecosystem. Microorganisms living in a particular ecosystem are also referred to as microbiota. Generally, these microorganisms flourish in the areas like saliva, gastrointestinal tract (GT), etc. These microorganisms include bacteria, archaebacteria, and fungi among many more. The health state of a person is highly dependent on such beneficial microbiomes. A healthy person houses a vast diversity of colonies of bacteria living together contributing to a healthier living of the person, and weigh about 3 pounds in an average adult. However, the lack of such diversity attracts numerous diseases.
 
Objectives of the Study:

  • Define and measure the global microbiome therapeutics market
  • Revenue forecast of the global microbiome therapeutics market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments
 
Market Dynamics
 
Increasing demand for treatments with high efficiency along with the increase in a number of inflammatory bowel disease and diabetes is expected to drive the market demand. Technological advancements, high acceptance, and increasing awareness are further supporting the market growth. However, high cost due to complexities in the development process and a limited set of regulations may hamper the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of microbiome therapeutics.
 
Market Segmentation
 
The broad microbiome therapeutics market has been sub-grouped into type and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Application Market Share 2017
 
Microbiome Therapeutics Market By Application
 
By Type
  • FMT
  • Microbiome Drugs
 
By Application
  • C. Difficile
  • Crohn’s Disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for microbiome therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Microbiome Therapeutics Market By Revenue (USD MN)
 
Europe Microbiome Therapeutics Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the microbiome therapeutics market includes Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome, and Seres Therapeutics Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
Major Company Players Market Share
 
Major Players of Microbiome Therapeutics Market
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1. INTRODUCTION

  • Introduction To Microbiome Therapeutics Market
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Microbiome Therapeutics Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY TYPE
  • Market In FMT
  • Market In Microbiome Drugs
 
5. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION
  • Market In C. Difficile
  • Market In Crohn’s Disease
  • Market In Inflammatory Bowel Disease
  • Market In Diabetes
  • Market In Others
 
6. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Canada Market Estimates By Segments
    • Mexico Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE MICROBIOME THERAPEUTICS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE MICROBIOME THERAPEUTICS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Enterome Bioscience
  • MaaT Pharma
  • MicroBiome Therapeutics LLC
  • OpenBiome
  • Rebiotix, Inc.
  • Ritter Pharmaceuticals Inc.
  • Second Genome
  • Seres Therapeutics Inc.
 
* Tentative TOC
 
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Microbiome Therapeutics
Table 2.  Global Microbiome Therapeutics Market By Types
Table 3.  Global Microbiome Therapeutics Market By Application
Table 4.  Global Microbiome Therapeutics Market By Geography
Table 5.  North America Microbiome Therapeutics Market
Table 6.  Europe Microbiome Therapeutics Market
Table 7.  Asia Pacific Microbiome Therapeutics Market
Table 8.  Latin America Microbiome Therapeutics Market
Table 9.  Middle East And Africa Microbiome Therapeutics Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments

LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Microbiome Therapeutics Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Microbiome Therapeutics
Fig. 5.     Value Chain Analysis
Fig. 6.     Porter’s Five Forces Analysis
Fig. 7.     Global Microbiome Therapeutics Market By Types
Fig. 8.     Global Microbiome Therapeutics Market By Application
Fig. 9.     Global Microbiome Therapeutics Market By Geography
Fig. 10.   North America Microbiome Therapeutics Market
Fig. 11.   Europe Microbiome Therapeutics Market
Fig. 12.   Asia Pacific Microbiome Therapeutics Market
Fig. 13.   Latin America Microbiome Therapeutics Market
Fig. 14.   Middle East And Africa Microbiome Therapeutics Market
Fig. 15.   Market Share Of Microbiome Therapeutics Companies
Fig. 16.   Recent Developments In Microbiome Therapeutics Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials